This page collects vetted references on medical safety, regulatory guidance, and clinical background for anyone researching this topic.
Understanding Follow-up care timeline for Avelumab-related Merkel Cell Carcinoma
A focused review of background, context, and source material on this subject.
Reference: Centers for Disease Control and Prevention (CDC)
Authoritative source for clinical, regulatory, and public-health background reading.
Reference: World Health Organization (WHO)
Authoritative source for clinical, regulatory, and public-health background reading.
Reference: U.S. Food and Drug Administration (FDA)
Authoritative source for clinical, regulatory, and public-health background reading.